Gardner FDA Law Firm: FDA’s View on Cannabis
The U.S. Food and Drug Administration (FDA) is continuing to support clinical research for cannabis and psychedelic drug development. On the heels of publishing its first draft guidance on clinical trials involving psychedelic drugs last year, the FDA acknowledged...
Bradley: The “Fix” Is In: Alabama Legislature to Consider Controversial Proposal to Revamp Stalled Medical Cannabis Program
By Whitt Steineker on April 3, 2024 Well, it’s here. Late yesterday afternoon Sens. Tim Melson and David Sessions introduced the long-awaited “legislative fix” to help get Alabama’s long-stalled Alabama medical cannabis licensing program off the ground. The proposal...Top 200 Cannabis Lawyers
We Support
Cannabis Law Report
- Board Member & Key Player of Harvest Health and Recreation, Daniel Reiner, 72, found dead in his private lake on Washington estate
- Florida – Study: Reasons for Use and Perceived Effects of Medical Cannabis: A Cross-Sectional Statewide Survey
- Paper: The impacts of packaging on preferences for cannabis edibles: A discrete choice experiment
- Paper: Examining the influence of cigar and cannabis co-marketing on packaging perceptions: An experiment with a sample of US youth
- Paper: Racial, ethnic, and neighborhood socioeconomic disparities in local cannabis retail policy in California
- OSHA Offices in Colorado Implement New Local Emphasis Program for the Cannabis Industry
- Thailand’s New Cannabis Law, (draft) Published September 14th 2024 (In Thai Only)
- MedMen Still Owe Rent Money In NY
- MJ Biz: Massachusetts voters could legalize psychedelics in November
- Alert Re Cannabis Product Marketing & Children